Zobrazeno 1 - 10
of 14
pro vyhledávání: '"J. B. Groce"'
Publikováno v:
Journal of Pharmacy Practice. 31:462-468
Background: Best practice recommendations are lacking. Thus far, literature has described pharmacist-led DOAC monitoring. Objective: The purpose of this study is to describe a DOAC monitoring program involving pharmacy students. Methods: This was an
Autor:
J. B. Groce
Publikováno v:
American Journal of Health-System Pharmacy. 64:S25-S29
Purpose. The evolution of evidence-based quality measures in healthcare, specific performance measures that have been developed by various groups for the prevention and treatment of venous thromboembolism (VTE), the objectives and potential benefits
Autor:
Gideon Bosker, Uri Elkayam, Allan L. Klein, John A. Heit, J. B. Groce, Alexander G.G. Turpie, Richard A. Grimm, Sarah A. Spinler, Samuel Z. Goldhaber, Niranjan Seshadri
Publikováno v:
American Heart Journal. 150:27-34
Background Recent labeling changes for enoxaparin, a low-molecular-weight heparin (LMWH), have prompted a reexamination of its role in patients with mechanical prosthetic heart valves (MPHVs). Healthcare providers are faced with the challenge of weig
Publikováno v:
Journal of Hospital Administration. 6:20
Objective: To pilot a process for identifying and switching high-risk warfarin patients to direct oral anticoagulants (DOACs) in nonvalvular atrial fibrillation (AF) or venous thromboembolism (VTE).Methods: A pharmacy resident identified high-risk wa
Publikováno v:
Journal of Geriatric Drug Therapy. 8:73-82
Publikováno v:
Annals of Pharmacotherapy. 27:1429-1433
OBJECTIVE: To compare heparin dosage adjustment using only activated partial thromboplastin time (APTT) with a method using non-steady-state heparin concentrations (HCs) to rapidly achieve and maintain an APTT ratio greater than or equal to 1.5 times
Autor:
E, Kalodiki, J, Fareed, V F, Tapson, D A, Hoppensteadt, I, Sussman, C A, Carter, S, Parker, J, Harenberg, R, Hull, G, Rao, D F, Lovinger, L D, Ried, A, Kakkar, L, Talarico, F, Ofuso, H I, Bussey, J, Fanikos, J B, Groce, N, Skinner, M, Ahluwalia, O, Iqbal, C M, Jackson, W P, Jeske, M, Georges, E, Ramacciotti, D, Van Thiel, R, Wahi, J, Walenga
Publikováno v:
International angiology : a journal of the International Union of Angiology. 29(2)
Publikováno v:
Therapeutic Drug Monitoring. 14:360-365
Heparin clearance and pharmacodynamic response were examined in 12 patients being treated for deep venous thrombosis (DVT, 6 patients) or pulmonary embolism (PE, 6 patients). A loading dose of 70 units/kg was administered to DVT patients and 100 unit
Autor:
J B, Groce
Publikováno v:
The American journal of managed care. 7
Because it eliminates the need for intravenous infusions and lengthy hospitalizations, use of low-molecular-weight heparins (LMWHs) for the treatment of deep vein thrombosis (DVT) can improve patient outcomes of safety and efficacy and reduce the cos
Publikováno v:
Journal of thrombosis and thrombolysis. 11(3)
Under pressure to provide cost-effective healthcare, many healthcare systems have adopted Therapeutic Interchange (TI) programs-the interchange of therapeutically equivalent but chemically unique drugs-to reduce the total cost of therapy without comp